Frontlight ResearchEarly access
Trial site
Azienda Socio Sanitaria Territoriale Rhodense
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis6 trials
- Crohn's disease3 trials
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Lead sponsor
- Eli Lilly & Co.2 trials
- Hoffmann-La Roche2 trials
- AbbVie1 trial
- Genentech, Inc.1 trial
- Janssen-Cilag Ltd.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis3 recruiting
- Crohn's disease2 recruiting
Site data: ClinicalTrials.govUpdated 14 Nov 2026